• Featured Product
  • KD/KO Validated

ABP1 Polyclonal antibody

ABP1 Polyclonal Antibody for IHC,ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IHC, IF

Conjugate

Unconjugated

Cat no : 16338-1-AP

Synonyms

ABP, ABP1, Amiloride binding protein, AOC1, DAO, DAO1, Diamine oxidase, Histaminase, KAO, Kidney amine oxidase



Tested Applications

Positive IHC detected inhuman kidney tissue, human placenta tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Immunohistochemistry (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

The immunogen of 16338-1-AP is ABP1 Fusion Protein expressed in E. coli.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen ABP1 fusion protein Ag9492
Full Name amiloride binding protein 1 (amine oxidase (copper-containing))
Calculated Molecular Weight 751 aa, 85 kDa
Observed Molecular Weight 85 kDa
GenBank Accession NumberBC014093
Gene Symbol ABP1
Gene ID (NCBI) 26
RRIDAB_2878245
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
IHC protocol for ABP1 antibody 16338-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB,IF

Front Pharmacol

Photodynamic Therapy of Novel Photosensitizer Ameliorates TNBS-Induced Ulcerative Colitis via Inhibition of AOC1.

Authors - Yumei Rong
  • KD Validated
humanWB

Cancer Manag Res

AOC1 Contributes to Tumor Progression by Promoting the AKT and EMT Pathways in Gastric Cancer.

Authors - Fen Xu
  • KD Validated